We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
694
Increased
1,955
Reduced
1,481
Closed
562

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.04B
2
CVX icon
Chevron
CVX
+$820M
3
SHOP icon
Shopify
SHOP
+$599M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$539M
5
META icon
Meta Platforms (Facebook)
META
+$479M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$675M
2
TSLA icon
Tesla
TSLA
+$661M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$633M
4
VZ icon
Verizon
VZ
+$533M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$377M

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WNW icon
4001
Meiwu Technology Co
WNW
$70M
$48K ﹤0.01%
+1
New +$47.4K
ELOX
4002
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$48K ﹤0.01%
+4,485
New +$61.9K
BCLI
4003
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$47K ﹤0.01%
+1,140
New +$51.3K
TOVX icon
4004
Theriva Biologics
TOVX
$11M
$47K ﹤0.01%
876
+446
+104% +$25.5K
SNAX
4005
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$47K ﹤0.01%
3,533
+1,820
+106% +$29.6K
CRXT
4006
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$47K ﹤0.01%
122,277
+87,577
+252% +$61.3K
AKTX
4007
Akari Therapeutics
AKTX
$12.6M
$46K ﹤0.01%
57
-1
-2% -$887
BINI
4008
DELISTED
Bollinger Innovations
BINI
– –
0
– –
TWAV
4009
TaoWeave Inc
TWAV
$4.77M
$46K ﹤0.01%
245
-102
-29% -$25.4K
QNTM
4010
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$22.4M
$46K ﹤0.01%
905
+403
+80% +$24.2K
EVK
4011
DELISTED
Ever-Glory International Group, Inc.
EVK
$46K ﹤0.01%
34,900
-1,100
-3% -$1.54K
ADAG
4012
Adagene
ADAG
$248M
$45K ﹤0.01%
+21,794
New +$65.9K
RMTI icon
4013
Rockwell Medical
RMTI
$29.6M
$45K ﹤0.01%
3,502
+945
+37% +$25K
UCL
4014
uCloudlink Group
UCL
$28.6M
$45K ﹤0.01%
40,005
+7,205
+22% +$8.53K
MOHO
4015
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$45K ﹤0.01%
276,707
-16,700
-6% -$3.32K
NMAD
4016
Nomad Power Solutions
NMAD
$71.9M
$43K ﹤0.01%
+5,719
New +$58.3K
ALAR
4017
Alarum Technologies
ALAR
$13.3M
$42K ﹤0.01%
8,602
+4,302
+100% +$25.3K
LGMK
4018
DELISTED
LogicMark
LGMK
$42K ﹤0.01%
+78
New +$58.1K
ORC
4019
Orchid Island Capital
ORC
$1.32B
$42K ﹤0.01%
+2,920
New +$43.4K
EFTR
4020
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$42K ﹤0.01%
+1,172
New +$70.9K
AVGR
4021
DELISTED
Avinger, Inc. Common Stock
AVGR
$42K ﹤0.01%
+1,931
New +$64K
AYLA
4022
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$42K ﹤0.01%
+38,101
New +$87K
DS
4023
DELISTED
Drive Shack Inc.
DS
$42K ﹤0.01%
30,328
-520,672
-94% -$742K
CRTD
4024
DELISTED
Creatd Inc. Common Stock
CRTD
$42K ﹤0.01%
+57,494
New +$53.1K
ATXS
4025
DELISTED
Astria Therapeutics
ATXS
$41K ﹤0.01%
+13,700
New +$61.4K
159 160
161
162 163

Similar funds

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Jim Simons's Q2 2022 Portfolio in Review

As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
  • Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Jim Simons opened 694 new positions and closed 562 in Q2 2022.
  • Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.